What happens next?: a claims database study of second-line pharmacotherapy in patients with major depressive disorder (MDD) who initiate selective serotonin reuptake inhibitor (SSRI) treatment

Aripiprazole augmentation for major depressive disorder

(2013) Chi-Un Pae et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

The Optimal Practice of Evidence-Based Medicine

(2013) Victor M. Montori et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010

(2013) Harvey A Whiteford et al.   LANCET

Dosing patterns of aripiprazole and quetiapine for adjunctive treatment of major depressive disorder (2006–2010)

(2012) Yonghua Jing et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study

(2012) D. Saragoussi et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Assessment of pharmacological strategies for management of major depressive disorder and their costs after an inadequate response to first-line antidepressant treatment in primary care

(2012) Antoni Sicras-Mainar et al.   Annals of General Psychiatry

Antidepressant monotherapy: A claims database analysis of treatment changes and treatment duration

(2010) Dominique Milea et al.   CLINICAL THERAPEUTICS

A Review of Current Guidelines for Depression Treatment

(2010) Alan J. Gelenberg   JOURNAL OF CLINICAL PSYCHIATRY